Pseudallescheria boydii infection after liver retransplantation [2]

Liver Transplantation

Volumn 13, Issue 7, 2007, Pages 1068-1069

  Bonatti, Hugo ^a,b   Goegele, Hannes ^a   Tabarelli, Dominique ^a   Muehlmann, Gilbert ^a   Sawyer, Robert ^b   Margreiter, Raimund ^a   Mark, Walter ^a   Flörl, Cornelia Lass ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CILASTATIN PLUS IMIPENEM; CYCLOSPORIN A; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ACUTE KIDNEY FAILURE; AGED; ANEURYSM; ARTERY STEAL SYNDROME; ARTIFICIAL EMBOLISM; BACTERIAL PNEUMONIA; CASE REPORT; CHOLESTASIS; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT FAILURE; HEMOFILTRATION; HEPATIC ARTERY; HEPATITIS C; HUMAN; HUMAN TISSUE; HYPOVOLEMIC SHOCK; KIDNEY CYST; KIDNEY HEMORRHAGE; LAPAROTOMY; LETTER; LEUKOCYTE DISORDER; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER PERFUSION; LIVER TRANSPLANTATION; LUNG INFILTRATE; MAXILLA SINUSITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIPLE ORGAN FAILURE; MYCOSIS; NEPHRECTOMY; PETRIELLIDIUM BOYDII; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETRANSPLANTATION; SEPSIS; SPLENOMEGALY; STOMATITIS; WOUND INFECTION;

HUMANS; LIVER TRANSPLANTATION; MADUROMYCOSIS; POSTOPERATIVE COMPLICATIONS; PSEUDALLESCHERIA; REOPERATION;

EID: 34547481317     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21120     Document Type: Letter

References (20)

1. Singh N, Pruett TL, Houston S, Munoz P, Cacciarelli TV, Wagener MM, et al. Invasive aspergillosis in the recipients of liver retransplantation. Liver Transpl 2006;12:1205-1209.
2. Husain S, Alexander BD, Munoz P, Avery RK, Houston S, Pruett T, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003;37:221-229.
3. Singh N, Avery RK, Munoz P, Pruett TL, Alexander B, Jacobs R, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003;36:46-52.
4. Hellinger WC, Bonatti H, Yao, JD, Alvarez S, Brumble LM, Keating MR, et al. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation. Liver Transpl. 2005;11:656-662.
5. Castroagudin JF, Ponton C, Bustamante M, Otero E, Martinez J, Tome S, et al. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients. Transplant Proc 2005;37:3965-3967.
6. Lass-Florl C, Griff K, Mayr A, Petzer A, Gastl G, Bonatti H, et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 2005;131:201-207.
7. Badiee P, Kordbacheh P, Alborzi A, Zeini F, Mirhendy H, Mahmoody M. Fungal infections in solid organ recipients. Exp Clin Transplant 2005:3:385-389.
8. Kauffman CA. Fungal infections. Proc Am Thorac Soc 2006;3:35-40.
9. Talbot TR, Hatcher J, Davis SF, Pierson RN III, Barton R, Dummer S. Scedosporlum apiospermum pneumonia and sternal wound infection in a heart transplant recipient. Transplantation 2002;74:1645-1647.
10. Luu KK, Scott IU, Miller D, Davis JL. Endogenous Pseudallescheria boydii endophthalmitis in a patient with ring-enhancing brain lesions. Ophthalmic Surg Lasers 2001; 32:325-329.
11. Hofman P, Saint-Paul MC, Gari-Toussaint M, Michiels JF, Boissy C, Jambou P, et al. Disseminated infection due to Scedosporium apiospermum in liver transplantation. Differential diagnosis from invasive aspergillosis [in French]. Ann Pathol 1993;13:332-335.
12. Welty FK, McLeod GX, Ezratty C, Healy RW, Karchmer AW. Pseudallescheria boydii endocarditis of the pulmonic valve in a liver transplant recipient. Clin Infect Dis 1992; 15:858-860.
13. Patterson TF, Andriole VT, Zervos MJ, Therasse D, Kauffman CA. The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses 1990;33:297-302.
14. Garci J, Perkins A, Garau M, Gene J, Molina L, del Palacio A. Successful treatment with voriconazol of a Pseudallescheria boydii fungus ball in a HIV positive patient and previous tuberculosis [in Spanish]. Rev Iberoam Micol 2003;20:64-67.
15. Perlroth MG, Miller J. Pseudoallescheria boydii pneumonia and empyema: a rare complication of heart transplantation cured with voriconazole. J Heart Lung Transplant 2004;23:647-649.
16. Bashir G, Shakeel S, Want T, Kakru DK. Pulmonary pseudallascheriasis in a patient with healed tuberculosis. Mycopathologia 2004;158:289-291.
17. Pfaller MA, Marco F, Messer SA, Jones RN. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn Microbiol Infect Dis 1998;30:251-255.
18. Zeng J, Kamei K, Zheng Y, Nishimura K. Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents. Nippon Ishinkin Gakkai Zasshi 2004;45:101-104.
19. Safdar A, Papadopoulos EB, Young JW. Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation. Scedosporiasis and recent advances in antifungal therapy. Transpl Infect Dis 2002;4:212-217.
20. Lodato F, Tame MR, Montagnani M, Sambri V, Liguori G, Azzaroli F, et al. Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: an emerging fungal agent. Liver Transpl. 2006;12:1711-1714.